Growth Metrics

Merck (MRK) EBITDA Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,446.00
Dec 31, 2025 -2,972.00
Sep 30, 2025 761.00
Jun 30, 2025 -687.00
Mar 31, 2025 1,381.00
Dec 31, 2024 213.00
Sep 30, 2024 -1,397.00
Jun 30, 2024 53.00
Mar 31, 2024 5,423.00
Dec 31, 2023 -4,922.00
Sep 30, 2023 7,074.00
Jun 30, 2023 -6,034.00
Mar 31, 2023 76.00
Dec 31, 2022 -31.00
Sep 30, 2022 -420.00
Jun 30, 2022 512.00
Mar 31, 2022 -352.00
Dec 31, 2021 -1,355.00
Sep 30, 2021 2,597.00
Jun 30, 2021 -1,017.00
Mar 31, 2021 6,719.00
Dec 31, 2020 -6,637.00
Sep 30, 2020 -274.00
Jun 30, 2020 -443.00
Mar 31, 2020 7,848.00
Dec 31, 2019 -6,086.00
Sep 30, 2019 -1,205.00
Jun 30, 2019 -135.00
Mar 31, 2019 637.00
Dec 31, 2018 261.00
Sep 30, 2018 388.00
Jun 30, 2018 560.00
Mar 31, 2018 -336.00
Dec 31, 2017 1,513.00
Sep 30, 2017 -2,327.00
Jun 30, 2017 427.00
Mar 31, 2017 3,663.00
Dec 31, 2016 -4,277.00
Sep 30, 2016 1,611.00
Jun 30, 2016 -15.00
Mar 31, 2016 878.00
Dec 31, 2015 -1,616.00
Sep 30, 2015 1,658.00
Jun 30, 2015 -690.00
Mar 31, 2015 -10,013.00
Dec 31, 2014 10,280.00
Sep 30, 2014 157.00
Jun 30, 2014 -980.00
Mar 31, 2014 1,222.00
Dec 31, 2013 -650.00
Sep 30, 2013 422.00
Jun 30, 2013 -503.00
Mar 31, 2013 150.00
Dec 31, 2012 -737.00
Sep 30, 2012 -507.00
Jun 30, 2012 141.00
Mar 31, 2012 807.00
Dec 31, 2011 -447.00
Sep 30, 2011 486.00
Jun 30, 2011 -138.00
Mar 31, 2011 2,239.00
Dec 31, 2010 -931.00
Sep 30, 2010 -404.00
Jun 30, 2010 -3,480.00
Mar 31, 2010 2,273.00
Dec 31, 2009 -4,349.00
Sep 30, 2009 295.00
Jun 30, 2009 247.00